GenomeWeb
GenomicWeb is a New York-based, privately held online B2B publisher operating as a business unit of Crain Communications. Founded in 1997, it delivers subscription-based news, analysis, and regulatory intelligence covering genetics, genomics, molecular diagnostics, and precision medicine to researchers, biotech executives, and clinical professionals.
- Company typePrivate
- Founded1997
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B
- OfferingDigital Commerce or Content
What GenomeWeb does
GenomicWeb is an independent, privately held online publisher founded in 1997 and headquartered in New York. It is operated as a business unit of Crain Communications Inc., a diversified B2B media company. The platform delivers daily news, analysis, and regulatory intelligence focused exclusively on the genetics, genomics, molecular diagnostics, and precision medicine sectors, organized across dedicated topic sections spanning business and policy, sequencing and other technologies, basic research, diagnostics, disease areas (oncology, infectious disease, rare disease, reproductive health, COVID-19), and applied markets. Sister publications 360Dx and Precision Medicine Online extend coverage into molecular diagnostics and precision medicine respectively, with shared audiences and cross-promotion within the Crain portfolio. PMLS Events rounds out an events franchise.
The core product is a web-based content management and publishing platform with subscription-based paywall controls, supporting premium articles, premium newsletters, RSS feed syndication, sponsored webinars, and white papers. The technology stack is standard digital publishing infrastructure; there is no proprietary AI, software platform, diagnostic test, or laboratory technology developed or sold by GenomicWeb. The publication functions as an editorial intelligence layer for the life sciences industry rather than a technology vendor.
GenomicWeb makes money through three streams: (1) recurring subscription revenue from individuals and enterprise buyers (researchers, biotech/diagnostics executives, healthcare professionals), sold on annual contracts with pricing available only on request; (2) display advertising and sponsored content targeting the genetics/genomics professional community; and (3) sponsored webinars, virtual events, and white papers sold as mid-funnel lead-generation and employer-branding products. Customer segments are predominantly researchers and academics, biotech and diagnostics companies, and clinical/pathology professionals, addressed through vertical segmentation and content marketing across website, email newsletters, RSS, social, webinars, and white papers.
GenomeWeb firmographics
Firmographics- Name
- GenomeWeb
- Legal name
- GenomeWeb
- Website
- https://genomeweb.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GenomicWeb is a New York-based, privately held online B2B publisher operating as a business unit of Crain Communications. Founded in 1997, it delivers subscription-based news, analysis, and regulatory intelligence covering genetics, genomics, molecular diagnostics, and precision medicine to researchers, biotech executives, and clinical professionals.
- Ownership category
- akta.pro rank
GenomeWeb industry classification
Industry- Product category
- Scientific News Publishing
- NAICS
- Web Search Portals, Libraries, Archives, and Other Information Services (5192)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA)
- akta.pro secondary industries
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
Keywords
Where GenomeWeb is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
GenomeWeb business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Subscription Revenue: Premium subscription model providing access to restricted content, analysis, and premium newsletters. Users can request annual quotes for subscriptions.
- Advertising and Sponsorships: Display advertising, sponsored content, and partnership opportunities targeting the genetics and genomics professional community.
- Webinars and Events: Sponsored webinar content and virtual events for companies seeking to reach the professional audience.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Premium Subscription |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
GenomeWeb product offering
Product offeringCore offering
GenomeWeb is an online business-to-business news and information service covering the genetics and genomics industry, including molecular diagnostics, precision medicine, and life sciences research. It publishes original daily journalism, analysis, and curated news, distributed through a subscription website, email newsletters, and sister publications such as 360Dx and Precision Medicine Online.
Product overview
GenomeWeb is a genetics and genomics news and information service operated by Crain Communications. It provides subscription-based premium content including news articles, research coverage, regulatory updates, and industry intelligence across areas such as molecular diagnostics, sequencing technology, proteomics, drug discovery, and clinical genomics. The service operates several sister publications (360Dx, Precision Medicine Online) and offers content through web platforms, newsletters, RSS feeds, webinars, white papers, and job listings. GenomeWeb does not develop or sell software products, diagnostic tests, or technology platforms—it functions as a media and intelligence platform for the life sciences and diagnostics industries.
Differentiator
Problem solved
Functional benefit
Brands
- 360Dx: Sister publication focused on molecular diagnostics and precision medicine
- Precision Medicine Online
Products and services
- GenomeWeb Premium Subscription Subscription access to GenomeWeb's daily news, in-depth features, and analysis on the genetics and genomics industry, targeted at researchers, clinicians, and industry professionals.
- 360Dx Sister publication covering news and analysis on the in vitro diagnostics industry, including regulatory, coverage, and reimbursement developments for diagnostic tests.
- Precision Medicine Online Sister publication focused on precision medicine, covering clinical applications of genomic and molecular testing, targeted therapies, and patient care advances.
- GenomeWeb Email Newsletters Topic-specific email newsletters delivering curated genetics and genomics news, product announcements, and industry updates to subscribers.
Companies that use GenomeWeb
Customer profileSegments3 records
Ideal customer profiles3 records
GenomeWeb technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
GenomeWeb partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- 360DxcoreSister publication focused on molecular diagnostics providing complementary coverage and shared audience within the Crain Communications portfolio.
- Precision Medicine OnlinecoreSister publication covering precision medicine topics with overlapping audience and cross-promotional opportunities within the genomics and diagnostics space.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
GenomeWeb competitors and assessment
Company assessmentDirect peers
- BioSpace: BioSpace is a life sciences news and job-listing platform serving biotech, pharma, and diagnostics professionals with daily news, company profiles, and career content. Direct peer in audience and revenue mix (advertising + job listings + events).
- STAT News: STAT is a subscription-supported health and life sciences news outlet covering biotech, pharma, and policy. Direct peer in subscription paywall model and B2B-leaning audience of researchers, executives, and investors in life sciences.
- Endpoints News: Subscription-based B2B biopharma news outlet founded by journalists, with a similar paywalled analysis model. Direct peer in monetizing premium biotech/pharma intelligence through subscription, sponsored content, and events.
- Drug Discovery & Development: Drug Discovery & Development covers pharma R&D and biotech research news and trends. Direct peer in serving life sciences R&D professionals with editorial coverage and sponsored content.
- Genetic Engineering & Biotechnology News (GEN): GEN is a long-running trade publication covering genetic engineering, biotechnology, and drug discovery. Closest direct competitor to GenomeWeb, serving overlapping audiences with similar news, analysis, and webinar offerings in the genomics/biotech space.
- Fierce Biotech / Fierce Pharma (Questex): Fierce Biotech and Fierce Pharma are subscription-supported B2B life sciences news outlets covering drug development, biotech deals, and regulatory news. Direct peer in audience (biotech/diagnostics professionals) and revenue model (subscription + advertising + events).
- Clinical OMICS: Clinical OMICS covers molecular diagnostics, genomics, and precision medicine news for clinicians and researchers. Direct peer targeting the diagnostics/genomics segment that is core to GenomeWeb's audience.
Emerging players
- 360Dx: 360Dx is GenomeWeb's sister publication under Crain Communications, focused specifically on molecular diagnostics. Highly comparable niche vertical, but smaller standalone footprint and owned by the same parent; serves as both internal synergy and adjacent competitor content.
- MedCity News: MedCity News covers healthcare innovation, digital health, and biotech business news with a B2B subscription-supported model. Emerging peer with overlapping biotech/diagnostics audience but broader healthcare coverage.
Broad incumbents
- Citeline / Informa Pharma Intelligence: Citeline (formerly Pharma Intelligence) is a large, established pharma/life sciences intelligence provider under Informa, offering paid databases, news, and analytics. Broad incumbent that competes for the same healthcare professional intelligence budget as GenomeWeb, though at much larger scale and broader scope.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
GenomeWeb social profiles
Digital presenceGenomeWeb financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenomeWeb leadership team
Management profileNumber of profiles
Profiles1 record
GenomeWeb funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenomeWeb M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenomeWeb
What does GenomeWeb do?
GenomeWeb is an online business-to-business news and information service covering the genetics and genomics industry, including molecular diagnostics, precision medicine, and life sciences research. It publishes original daily journalism, analysis, and curated news, distributed through a subscription website, email newsletters, and sister publications such as 360Dx and Precision Medicine Online.
Is GenomeWeb a public or private company?
GenomeWeb is a private company. It is classified as corporate owned and is currently operating.
When was GenomeWeb founded?
GenomeWeb was founded in 1997. It employs 11 to 50 people.
Where is GenomeWeb based?
GenomeWeb is headquartered in New York, United States, in the North America region.
How does GenomeWeb make money?
Three revenue lines are on record. Subscription Revenue is the primary driver. The others are advertising and Sponsorships and webinars and Events.
Who are GenomeWeb's main competitors?
Direct peers on record are BioSpace, STAT News, Endpoints News, Drug Discovery & Development, Genetic Engineering & Biotechnology News (GEN), Fierce Biotech / Fierce Pharma (Questex) and Clinical OMICS. Emerging players are 360Dx and MedCity News. Citeline / Informa Pharma Intelligence is listed as a broad incumbent.
Does GenomeWeb have an API?
No public API is recorded for GenomeWeb.
What industry is GenomeWeb in?
GenomeWeb's product category is Scientific News Publishing. Its primary akta.pro industry code is HLAGANAA, Genomics & Next-Generation Sequencing (NGS) Services, with a secondary code of HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays). Its NAICS code is 5192 and its SIC code is 2721.